Eμ/miR-125b transgenic mice develop lethal B-cell malignancies

MicroRNA-125b-1 (miR-125b-1) is a target of a chromosomal translocation t(11;14)(q24;q32) recurrently found in human B-cell precursor acute lymphoblastic leukemia (BCP-ALL). This translocation results in overexpression of miR-125b controlled by immunoglobulin heavy chain gene (IGH) regulatory elements. In addition, we found that six out of twenty-one BCP-ALL patients without t(11;14)(q24;q32) showed overexpression of miR-125b. Interestingly, four out of nine patients with BCR/ABL-positive BCP-ALL and one patient with B-cell lymphoid crisis that had progressed from chronic myelogenous leukemia overexpressed miR-125b. To examine the role of the deregulated expression of miR-125b in the development of B-cell tumor in vivo, we generated transgenic mice mimicking the t(11;14)(q24;q32) (Eμ/miR-125b-TG mice). Eμ/miR-125b-TG mice overexpressed miR-125b driven by IGH enhancer and promoter and developed IgM-negative or IgM-positive lethal B-cell malignancies with clonal proliferation. B cells obtained from the Eμ/miR-125b-TG mice were resistant to apoptosis induced by serum starvation. We identified Trp53inp1, a pro-apoptotic gene induced by cell stress, as a novel target gene of miR-125b in hematopoietic cells in vitro and in vivo. Our results provide direct evidence that miR-125b has important roles in the tumorigenesis of precursor B cells.

[1]  M. Dyer,et al.  The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. , 2000, Blood.

[2]  R. Tomasini,et al.  Molecular and Functional Characterization of the Stress-induced Protein (SIP) Gene and Its Two Transcripts Generated by Alternative Splicing , 2001, The Journal of Biological Chemistry.

[3]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[4]  Y Taya,et al.  p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. , 2001, Molecular cell.

[5]  Richard Tomasini,et al.  P53-dependent expression of the stress-induced protein (SIP). , 2002, European journal of cell biology.

[6]  Daniel Isnardon,et al.  TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity* , 2003, Journal of Biological Chemistry.

[7]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[8]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[9]  Hideaki Nakajima,et al.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. , 2005, The Journal of clinical investigation.

[10]  N Asou,et al.  Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia , 2005, Leukemia.

[11]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Takashi Akasaka,et al.  Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). , 2007, Blood.

[13]  Ladan Fazli,et al.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development , 2007, Proceedings of the National Academy of Sciences.

[14]  Victor L. J. Tybulewicz,et al.  Functional Analysis of Activating Receptor LMIR4 as a Counterpart of Inhibitory Receptor LMIR3* , 2007, Journal of Biological Chemistry.

[15]  Bernard Malissen,et al.  Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1 , 2007, Molecular and Cellular Biology.

[16]  Hideaki Nakajima,et al.  Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. , 2008, Blood.

[17]  Frank J. Slack,et al.  MicroRNAs and cancer: An overview , 2008, Cell cycle.

[18]  Dominique Leroux,et al.  Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation , 2008, The Journal of experimental medicine.

[19]  Hironori Harada,et al.  Possible involvement of RasGRP4 in leukemogenesis , 2009, International journal of hematology.

[20]  Yutaka Enomoto,et al.  An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcRγ in Mast Cells1 , 2009, The Journal of Immunology.

[21]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Todd R. Golub,et al.  MicroRNA miR-125a controls hematopoietic stem cell number , 2010, Proceedings of the National Academy of Sciences.

[23]  Aadel A. Chaudhuri,et al.  MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output , 2010, Proceedings of the National Academy of Sciences.

[24]  Concetta Micalizzi,et al.  MicroRNA‐125b‐1 and BLID upregulation resulting from a novel IGH translocation in childhood B‐Cell precursor acute lymphoblastic leukemia , 2010, Genes, chromosomes & cancer.

[25]  J Kitaura,et al.  AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model , 2010, Leukemia.

[26]  Noam Shomron,et al.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 , 2009, Leukemia.

[27]  Beiyan Zhou,et al.  MicroRNA miR-125b causes leukemia , 2010, Proceedings of the National Academy of Sciences.

[28]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[29]  Yutaka Enomoto,et al.  Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor , 2010, The Journal of Biological Chemistry.

[30]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[31]  Debashis Sahoo,et al.  MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets , 2010, Proceedings of the National Academy of Sciences.

[32]  I Radford-Weiss,et al.  A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia , 2010, Leukemia.

[33]  Fumio Nakahara,et al.  Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. , 2011, Blood.